These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 29627062)

  • 1. Immune active cells with 4-1BB signal enhancement inhibit hepatitis B virus replication in noncytolytic manner.
    Wang L; Yi Y; Jiang W; Yin D; Fan J; Ye W; Zhao W
    Cell Immunol; 2018 Jun; 328():79-85. PubMed ID: 29627062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon-γ and Tumor Necrosis Factor-α Produced by T Cells Reduce the HBV Persistence Form, cccDNA, Without Cytolysis.
    Xia Y; Stadler D; Lucifora J; Reisinger F; Webb D; Hösel M; Michler T; Wisskirchen K; Cheng X; Zhang K; Chou WM; Wettengel JM; Malo A; Bohne F; Hoffmann D; Eyer F; Thimme R; Falk CS; Thasler WE; Heikenwalder M; Protzer U
    Gastroenterology; 2016 Jan; 150(1):194-205. PubMed ID: 26416327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-35 Suppresses Antiviral Immune Response in Chronic Hepatitis B Virus Infection.
    Shao X; Ma J; Jia S; Yang L; Wang W; Jin Z
    Front Cell Infect Microbiol; 2017; 7():472. PubMed ID: 29181338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD8(+) T cell control of hepatitis B virus replication: direct comparison between cytolytic and noncytolytic functions.
    Phillips S; Chokshi S; Riva A; Evans A; Williams R; Naoumov NV
    J Immunol; 2010 Jan; 184(1):287-95. PubMed ID: 19949099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural Killer p46 Controls Hepatitis B Virus Replication and Modulates Liver Inflammation.
    Li W; Jiang Y; Wang X; Jin J; Qi Y; Chi X; Zhang H; Feng X; Niu J
    PLoS One; 2015; 10(8):e0135874. PubMed ID: 26291078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokine-sensitive replication of hepatitis B virus in immortalized mouse hepatocyte cultures.
    Pasquetto V; Wieland SF; Uprichard SL; Tripodi M; Chisari FV
    J Virol; 2002 Jun; 76(11):5646-53. PubMed ID: 11991993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequency and role of NKp46 and NKG2A in hepatitis B virus infection.
    Yoshioka T; Tatsumi T; Miyagi T; Mukai K; Nishio K; Nishio A; Yokoyama Y; Suda T; Kegasawa T; Shigekawa M; Hikita H; Sakamori R; Takehara T
    PLoS One; 2017; 12(3):e0174103. PubMed ID: 28328926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of IL-18 on peripheral blood mononuclear cells of chronic hepatitis B and hepatitis B virus DNA released by HepG2.2.15 cell lines.
    Sun Y; Chen HY; Xin SJ
    Hepatobiliary Pancreat Dis Int; 2004 May; 3(2):230-4. PubMed ID: 15138116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccination with ubiquitin-hepatitis B core antigen-cytoplasmic transduction peptide enhances the hepatitis B virus-specific cytotoxic T-lymphocyte immune response and inhibits hepatitis B virus replication in transgenic mice.
    Zhuo M; Song L; Tang Y; Dai S; Chen X; Yu Y; Zang G; Tang Z
    Mol Med Rep; 2015 Sep; 12(3):3591-3598. PubMed ID: 26004262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokine inhibition of the hepatitis B virus core promoter.
    Romero R; Lavine JE
    Hepatology; 1996 Jan; 23(1):17-23. PubMed ID: 8550037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PD-1/PDL1 and CD28/CD80 pathways modulate natural killer T cell function to inhibit hepatitis B virus replication.
    Wang XF; Lei Y; Chen M; Chen CB; Ren H; Shi TD
    J Viral Hepat; 2013 Apr; 20 Suppl 1():27-39. PubMed ID: 23458522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NKG2D modulates aggravation of liver inflammation by activating NK cells in HBV infection.
    Wang Y; Wang W; Shen C; Wang Y; Jiao M; Yu W; Yin H; Shang X; Liang Q; Zhao C
    Sci Rep; 2017 Mar; 7(1):88. PubMed ID: 28273905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory effect of the combination of CpG-induced cytokines with lamivudine against hepatitis B virus replication in vitro.
    Vincent IE; Lucifora J; Durantel D; Hantz O; Chemin I; Zoulim F; Trepo C
    Antivir Ther; 2009; 14(1):131-5. PubMed ID: 19320247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activating the innate immune response to counter chronic hepatitis B virus infection.
    Lamb C; Arbuthnot P
    Expert Opin Biol Ther; 2016 Dec; 16(12):1517-1527. PubMed ID: 27603796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HBV-specific immune defect in chronic hepatitis B (CHB) is correlated with a dysregulation of pro- and anti-inflammatory cytokines.
    Schlaak JF; Tully G; Löhr HF; Gerken G; Meyer zum Büschenfelde KH
    Clin Exp Immunol; 1999 Mar; 115(3):508-14. PubMed ID: 10193426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imbalanced intrahepatic cytokine expression of interferon-gamma, tumor necrosis factor-alpha, and interleukin-10 in patients with acute-on-chronic liver failure associated with hepatitis B virus infection.
    Zou Z; Li B; Xu D; Zhang Z; Zhao JM; Zhou G; Sun Y; Huang L; Fu J; Yang Y; Jin L; Zhang W; Zhao J; Sun Y; Xin S; Wang FS
    J Clin Gastroenterol; 2009 Feb; 43(2):182-90. PubMed ID: 18633332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transfusion of autologous cytokine-induced killer cells inhibits viral replication in patients with chronic hepatitis B virus infection.
    Shi M; Fu J; Shi F; Zhang B; Tang Z; Jin L; Fan Z; Zhang Z; Chen L; Wang H; Lau GK; Wang FS
    Clin Immunol; 2009 Jul; 132(1):43-54. PubMed ID: 19328038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Alterations of IFN-γ and IL-4 of peripheral blood T cells in patients with chronic HBV infection].
    Li M; Sun X; Zhou Z; Zhang X; Jin S; Gao Y; Gao Y
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Feb; 32(2):240-4. PubMed ID: 26927386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histone deacetylases and acetylated histone H3 are involved in the process of hepatitis B virus DNA replication.
    Zhang D; Wang Y; Zhang HY; Jiao FZ; Zhang WB; Wang LW; Zhang H; Gong ZJ
    Life Sci; 2019 Apr; 223():1-8. PubMed ID: 30862568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of antiviral T-cell responses with suppression of viral rebound in chronic hepatitis B carriers: a proof-of-concept study.
    Yang SH; Lee CG; Park SH; Im SJ; Kim YM; Son JM; Wang JS; Yoon SK; Song MK; Ambrozaitis A; Kharchenko N; Yun YD; Kim CM; Kim CY; Lee SH; Kim BM; Kim WB; Sung YC
    Gene Ther; 2006 Jul; 13(14):1110-7. PubMed ID: 16525482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.